FDA Recalls Cholesterol Medication for Safety Concerns – WSOC TV
The U.S. Food and Drug Administration (FDA) has announced a significant recall of atorvastatin, a widely used medication for managing cholesterol levels. The recall affects over 140,000 bottles of this common statin due to safety concerns.
Details of the Atorvastatin Recall
Atorvastatin is primarily prescribed to lower cholesterol and triglyceride levels, helping to prevent heart disease. The recent recall impacts various manufacturers and distributors of atorvastatin pills.
Safety Concerns Raised
The recall was initiated after reports of potential contamination that could compromise the medication’s effectiveness. The FDA emphasized the importance of patient safety, urging consumers to check their medication supplies.
Impacted Products
- Atorvastatin tablets (various dosages)
- Affecting over 140,000 bottles nationwide
What to Do If You Are Affected
If you have atorvastatin in your possession, it is vital to verify whether your bottles are among those recalled. Consult your pharmacist or healthcare provider for guidance. Do not stop taking your medication without professional advice.
Additional Information
The FDA is actively working with manufacturers to ensure that affected products are promptly removed from the market. Consumers can report any adverse effects or problems related to atorvastatin directly to the FDA.
